רווח תפעולי לפני ניכוי פחת: GeoVax (GOVX)

GeoVax Labs, Inc. (GOVX) is managed by experienced scientists who ensure trial transparency and strict capital control. The history of operating profit in monetary terms on the GURU.Markets chart shows that the parameter has stabilized at 0.00. Current growth is supported by US government grants for COVID-19 vaccines, while management's strategic focus on breakthrough immunotherapy for cancer and infections opens new horizons for development.

During fundamental asset screening, this indicator serves as a filter to separate actual cash flows from accounting adjustments. By analyzing EBITDA fluctuations, an investor can identify net operating profit before taxes and interest, which is critically important for GeoVax Labs, Inc. (GOVX) when assessing R&D costs and navigating FDA certification stages.